Wells Fargo & Company Ac Immune Sa Transaction History
Wells Fargo & Company
- $468 Billion
- Q2 2025
A detailed history of Wells Fargo & Company transactions in Ac Immune Sa stock. As of the latest transaction made, Wells Fargo & Company holds 1,024,608 shares of ACIU stock, worth $2.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,024,608
Previous 997,621
2.71%
Holding current value
$2.2 Million
Previous $1.87 Million
11.47%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding ACIU
# of Institutions
43Shares Held
26.7MCall Options Held
0Put Options Held
28.5K-
Bvf Inc San Francisco, CA19.8MShares$42.6 Million1.58% of portfolio
-
Black Rock Inc. New York, NY2.61MShares$5.61 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny828KShares$1.78 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA412KShares$885,1460.0% of portfolio
-
Northern Trust Corp Chicago, IL381KShares$819,9110.0% of portfolio
About AC Immune SA
- Ticker ACIU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,413,504
- Market Cap $179M
- Description
- AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...